Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection
- PMID: 10934347
- DOI: 10.1002/1098-1128(200009)20:5<323::aid-med1>3.0.co;2-a
Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection
Abstract
A large variety of natural products have been described as anti-HIV agents, and for a portion thereof the target of interaction has been identified. Cyanovirin-N, a 11-kDa protein from Cyanobacterium (blue-green alga) irreversibly inactivates HIV and also aborts cell-to-cell fusion and transmission of HIV, due to its high-affinity interaction with gp120. Various sulfated polysaccharides extracted from seaweeds (i.e., Nothogenia fastigiata, Aghardhiella tenera) inhibit the virus adsorption process. Ingenol derivatives may inhibit virus adsorption at least in part through down-regulation of CD4 molecules on the host cells. Inhibition of virus adsorption by flavanoids such as (-)epicatechin and its 3-O-gallate has been attributed to an irreversible interaction with gp120 (although these compounds are also known as reverse transcriptase inhibitors). For the triterpene glycyrrhizin (extracted from the licorice root Glycyrrhiza radix) the mode of anti-HIV action may at least in part be attributed to interference with virus-cell binding. The mannose-specific plant lectins from Galanthus, Hippeastrum, Narcissus, Epipac tis helleborine, and Listera ovata, and the N-acetylgl ucosamine-specific lectin from Urtica dioica would primarily be targeted at the virus-cell fusion process. Various other natural products seem to qualify as HIV-cell fusion inhibitors: the siamycins [siamycin I (BMY-29304), siamycin II (RP 71955, BMY 29303), and NP-06 (FR901724)] which are tricyclic 21-amino-acid peptides isolated from Streptomyces spp that differ from one another only at position 4 or 17 (valine or isoleucine in each case); the betulinic acid derivative RPR 103611, and the peptides tachyplesin and polyphemusin which are highly abundant in hemocyte debris of the horseshoe crabs Tachypleus tridentatus and Limulus polyphemus, i.e., the 18-amino-acid peptide T22 from which T134 has been derived. Both T22 and T134 have been shown to block T-tropic X4 HIV-1 strains through a specific antagonism with the HIV corecept or CXCR4. A number of natural products have been reported to interact with the reverse transcriptase, i.e., baicalin, avarol, avarone, psychotrine, phloroglucinol derivatives, and, in particular, calanolides (from the tropical rainforest tree, Calophyllum lanigerum) and inophyllums (from the Malaysian tree, Calophyllum inophyllum). The natural marine substance illimaquinone would be targeted at the RNase H function of the reverse transcriptase. Curcumin (diferuloylmethane, from turmeric, the roots/rhizomes of Curcuma spp), dicaffeoylquinic and dicaffeoylt artaric acids, L-chicoric acid, and a number of fungal metabolites (equisetin, phomasetin, oteromycin, and integric acid) have all been proposed as HIV-1 integrase inhibitors. Yet, we have recently shown that L-c hicoric acid owes its anti-HIV activity to a specific interaction with the viral envelope gp120 rather than integrase. A number of compounds would be able to inhibit HIV-1 gene expression at the transcription level: the flavonoid chrysin (through inhibition of casein kinase II, the antibacter ial peptides melittin (from bee venom) and cecropin, and EM2487, a novel substance produced by Streptomyces. (ABSTRACT TRUNCATED)
Similar articles
-
Natural products with anti-HIV activity from marine organisms.Curr Top Med Chem. 2003;3(13):1512-35. doi: 10.2174/1568026033451790. Curr Top Med Chem. 2003. PMID: 14529524 Review.
-
New developments in anti-HIV chemotherapy.Curr Med Chem. 2001 Nov;8(13):1543-72. doi: 10.2174/0929867013371842. Curr Med Chem. 2001. PMID: 11562282 Review.
-
Novel compounds in preclinical/early clinical development for the treatment of HIV infections.Rev Med Virol. 2000 Jul-Aug;10(4):255-77. doi: 10.1002/1099-1654(200007/08)10:4<255::aid-rmv282>3.0.co;2-6. Rev Med Virol. 2000. PMID: 10891872 Review.
-
Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.Antimicrob Agents Chemother. 1992 Jun;36(6):1249-55. doi: 10.1128/AAC.36.6.1249. Antimicrob Agents Chemother. 1992. PMID: 1384424 Free PMC article.
-
New developments in anti-HIV chemotherapy.Biochim Biophys Acta. 2002 Jul 18;1587(2-3):258-75. doi: 10.1016/s0925-4439(02)00089-3. Biochim Biophys Acta. 2002. PMID: 12084468 Review.
Cited by
-
Antiviral activity of chrysin and naringenin against porcine epidemic diarrhea virus infection.Front Vet Sci. 2023 Dec 7;10:1278997. doi: 10.3389/fvets.2023.1278997. eCollection 2023. Front Vet Sci. 2023. PMID: 38130439 Free PMC article.
-
Bibliometric analysis and visualization of research trends on HIV-1 capsid inhibitors (2000-2022).Front Pharmacol. 2023 Oct 23;14:1282090. doi: 10.3389/fphar.2023.1282090. eCollection 2023. Front Pharmacol. 2023. PMID: 37936907 Free PMC article.
-
Biological properties and potential of compounds extracted from red seaweeds.Phytochem Rev. 2022 Jul 1:1-32. doi: 10.1007/s11101-022-09826-z. Online ahead of print. Phytochem Rev. 2022. PMID: 35791430 Free PMC article. Review.
-
Isolation, Screening, and Active Metabolites Identification of Anti-Vibrio Fungal Strains Derived From the Beibu Gulf Coral.Front Microbiol. 2022 Jun 2;13:930981. doi: 10.3389/fmicb.2022.930981. eCollection 2022. Front Microbiol. 2022. PMID: 35722281 Free PMC article.
-
Equisetin is an anti-obesity candidate through targeting 11β-HSD1.Acta Pharm Sin B. 2022 May;12(5):2358-2373. doi: 10.1016/j.apsb.2022.01.006. Epub 2022 Jan 15. Acta Pharm Sin B. 2022. PMID: 35646525 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
